Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. N-(2-amino-5-fluorobenzyl)-4-(n-(pyridine-3-acrylyl)aminomethyl)benzamide
1. 743420-02-2
2. 1883690-47-8
3. (e)-n-(2-amino-5-fluorophenyl)-4-((3-(pyridin-3-yl)acrylamido)methyl)benzamide
4. Hdac-in-7
5. Chembl4087968
6. N-(2-amino-5-fluorophenyl)-4-[[[(e)-3-pyridin-3-ylprop-2-enoyl]amino]methyl]benzamide
7. 462284yv3m
8. N-(2-amino-5-fluorophenyl)-4-((3-(pyridin-3-yl)acrylamido)methyl)benzamide
9. Benzamide, N-(2-amino-5-fluorophenyl)-4-(((1-oxo-3-(3-pyridinyl)-2-propen-1-yl)amino)methyl)-
10. N-(2-amino-5-fluorophenyl)-4-(((1-oxo-3-(3-pyridinyl)-2-propen-1-yl)amino)methyl)benzamide
11. N-(2-amino-5-fluorophenyl)-4-[[[1-oxo-3-(3-pyridinyl)-2-propen-1-yl]amino]methyl]benzamide
12. Tucidinostat(chidamide)
13. Tucidinostat (chidamide)
14. Schembl8057949
15. Unii-462284yv3m
16. Dtxsid801348099
17. Ex-a2209
18. Chidamide; Cs055; Hbi-8000
19. Bdbm50242817
20. Hbi-8000;cs-055
21. Mfcd18382123
22. S8567
23. Zinc64857905
24. Ccg-208658
25. Cs-3554
26. Ncgc00263598-10
27. As-47017
28. Hy-13592
29. F11457
30. A901614
31. Q27075960
32. N-(2-amino-5-fluorophenyl)-4-{[(2e)-3-(3-pyridinyl)-2-propenamido]methyl}benzamide
| Molecular Weight | 390.4 g/mol |
|---|---|
| Molecular Formula | C22H19FN4O2 |
| XLogP3 | 2.3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 390.14920402 g/mol |
| Monoisotopic Mass | 390.14920402 g/mol |
| Topological Polar Surface Area | 97.1 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 577 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Chidamide Analog manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chidamide Analog, including repackagers and relabelers. The FDA regulates Chidamide Analog manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chidamide Analog API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Chidamide Analog supplier is an individual or a company that provides Chidamide Analog active pharmaceutical ingredient (API) or Chidamide Analog finished formulations upon request. The Chidamide Analog suppliers may include Chidamide Analog API manufacturers, exporters, distributors and traders.
Chidamide Analog Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chidamide Analog GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chidamide Analog GMP manufacturer or Chidamide Analog GMP API supplier for your needs.
A Chidamide Analog CoA (Certificate of Analysis) is a formal document that attests to Chidamide Analog's compliance with Chidamide Analog specifications and serves as a tool for batch-level quality control.
Chidamide Analog CoA mostly includes findings from lab analyses of a specific batch. For each Chidamide Analog CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chidamide Analog may be tested according to a variety of international standards, such as European Pharmacopoeia (Chidamide Analog EP), Chidamide Analog JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chidamide Analog USP).
LOOKING FOR A SUPPLIER?
